• 1
    Banchereau J. & Steinman R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245.
  • 2
    Adema G.J., Hartgers F., Verstraten R. et al. (1997) A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387, 713.
  • 3
    Sallusto F., Lanzavecchia A., Mackay C.R. (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19, 568.DOI: 10.1016/s0167-5699(98)01346-2
  • 4
    Sallusto F. & Lanzavecchia A. (1999) Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189, 611.
  • 5
    Sarsfield P., Jones D.B., Wright D.H. (1996) Accessory cells in Crohn's disease of the terminal ileum. Histopathology 28, 213.
  • 6
    Thomas R. & Quinn C. (1996) Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium. J Immunol 156, 3074.
  • 7
    Molne J., Jansson S., Ericson L.E., Nilsson M. (1994) Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease. Autoimmunity 17, 59.
  • 8
    Voorby H.A., Kabel P.J., De Haan M. et al. (1990) Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 55, 9.
  • 9
    Lo D., Reilly C.R., Scott B., Liblau R., McDewitt H.O., Burkly L.C. (1993) Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur J Immunol 23, 1693.
  • 10
    Green E.A., Eynon E.E., Flavell R.A. (1998) Local expression of TNF-α in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9, 733.
  • 11
    Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. (1998) Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 188, 1493.
  • 12
    O'brien W.M. (1983) Pharmacology of nonsteroidal anti-inflammatory drugs. Practical review for clinicians. Am J Med 75, 32.
  • 13
    Crout J.E., Hepburn B., Ritts R.E. Jr (1975) Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med 292, 221.
  • 14
    Bellosillo B., Pique M., Barragan M. et al. (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92, 1406.
  • 15
    United States Pharmacopeial Convention. (2000) Salicylates (systemic). . In: United States Pharmacopeia/National Formulary, Drug Information for the Health Professional, Vol. I, p. 2734. Micromedex Inc., Englewood, CO.
  • 16
    Abramson S.B. & Weissmann G. (1989) The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 32, 1.
  • 17
    Hausser G., Burkhard L., Gelderblom H.R., Tsunetsugu-Yokota Y., Akagawa K., Meyerhans A. (1997) Monocyte-derived dendritic cells represent a transient stage of differentiation in the myeloid lineage. Immunobiology 197, 534.
  • 18
    Palucka K.A., Taquet N., Sanchez-Chapuis F., Gluckman J.C. (1998) Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 160, 4587.
  • 19
    Reddy A., Sapp M., Feldman M., Subklewe M., Bhardwaj N. (1997) A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 9, 3649.
  • 20
    Jonuleit H., Kuhn U., Muller G. et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27, 3135.
  • 21
    Kolb H.J., Schattenberg A., Goldman J.M. et al. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86, 2041.
  • 22
    Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. (1998) Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188, 2175.
  • 23
    Oyama T., Ran S., Ishida T. et al. (1998) Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells. J Immunol 160, 1224.
  • 24
    Pahl H.L. & Bauerle P.A. (1996) Activation of NF-κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers. FEBS Lett 392, 129.
  • 25
    Kishimoto T., Kikutani H., Von Dem Borne A.E.G.K. et al. (1997) White cell differentiation antigens. In: Leukocyte Typing (eds KishimotoT., KikutaniH. et al.), Vol VI, p. 927 1221. Garland Publishing, New York.
  • 26
    Cryer B. & Feldman M. (1998) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104, 413.
  • 27
    Schwenger P., Bellosta P., Vietor I., Basilico C., Skolnik E., Vilcek J. (1997) Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced C-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94, 2869.
  • 28
    Verhoven B., Schlegel R.A., Williamson P. (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182, 1597.
  • 29
    Rieseries C., Bock G., Klocker H., Bartsch G., Thurnher M. (1997) Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186, 1603.
  • 30
    Burkly L., Hession C., Ogata L. et al. (1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531.
  • 31
    Kopp E. & Ghosh S. (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956.
  • 32
    Ni K. & O'neill H.C. (1997) The role of dendritic cells in T cell activation. Immunol Cell Biol 75, 223.
  • 33
    Yin M., Yamamoto Y., Gaynor R.B. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396, 77.
  • 34
    Dong Z., Huang C., Brown R.E., Ma W.-Y. (1997) Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272, 9962.
  • 35
    Grilli M., Chiu J.S., Lenardo M.J. (1993) NF-κB and rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143, 1.
  • 36
    Baldwin A.S. (1995) The NF-κB and IκB proteins: new discoveries and insights. Science 274, 782.
  • 37
    Bauerle P.A. & Henkel T. (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12, 141.
  • 38
    Beg A.A. & Baltimore D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782.
  • 39
    Wallach D. (1997) Cell death induction by TNF: a matter of self-control. Trends Biochem Sci 22, 107.
  • 40
    Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787.
  • 41
    Wu M., Lee H., Bellas R.E. et al. (1996) Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15, 4682.
  • 42
    Shackelford R.E., Alford P.B., Xue Y., Thai S.F., Adams D.O., Pizzo S. (1997) Aspirin inhibits tumor necrosis factor α gene expression in murine tissue macrophages. Mol Pharmacol 52, 421.
  • 43
    Pillinger M.H., Capodici C., Rosenthal P., Kheterpal N., Hanft S., Philips M.R. (1998) Modes of action of aspirin-like drugs: salicylates inhibit ERK activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 95, 14540.